Study Finds Unchecked Additives in Majority of Compounded Weight-Loss Drugs
Recent research published in JAMA reveals that compounded GLP-1 medications, which now comprise a large portion of weight-loss prescriptions, frequently feature untested additives like vitamin B12 analogs.
🧠AI AnalysisPhoto: Medical Xpress
Key points
- Compounded GLP-1 medications accounted for 86% of compounded weight-loss prescriptions by 2025 in the Nebraska dataset.
- Commonly added substances include vitamin B12 analogs and levocarnitine without established safety data.
- Cash-pay purchases make these products largely invisible to traditional insurance claims tracking.
A recent investigation published in the journal JAMA highlights that the vast majority of compounded weight-loss medications now consist of GLP-1 receptor agonists mixed with additional active ingredients. Led by researchers from the University of Utah Health Sciences, the study examined dispensing patterns using a comprehensive prescription tracking database from Nebraska, noting that these compounded formulations surged from nonexistence in 2018 to account for 86 percent of all compounded weight-loss prescriptions by 2025.
Many of these alternative formulations incorporate substances such as cyanocobalamin, a vitamin B12 analog, and levocarnitine. Vendors often market these additives as a way to mitigate common side effects associated with GLP-1 treatments. However, the study points out that these specific combinations lack formal safety testing, and evidence supporting their efficacy remains scarce.
Because the cash-pay nature of these products generally bypasses standard insurance claims databases, tracking their distribution has proven difficult. Lead author Joey Mattingly notes that compounded alternatives differ significantly from FDA-approved medications, leaving the overall quality, composition, and potential risks largely unverified for patients who inject them.
What to know: Patients and physicians should carefully verify the origin of weight-loss medications, as compounded GLP-1s often contain unmonitored additives. Always consult a qualified healthcare provider regarding personal treatment decisions and medication safety.
Source Medical Xpress — medicalxpress.com/news/2026-11-glp-1s-untested-additive-combinations.ht… ↗
Read next
🏃FitnessUnderstanding and Addressing Love Handles Through Lifestyle Changes
Experts clarify that spot reduction of fat is not physiologically possible, recommending a combination of calorie management and high-intensity interval training instead.
🏃FitnessCiele Releases New Woolmark-Certified Merino Winter Running Apparel
Montreal-based brand Ciele has launched its second collection of merino wool running gear, featuring performance-focused fabrics designed for cold-weather training.
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.